// Company Overview //
| Stock Name | 聯合醫務集團有限公司 |
|---|
| Stock Code | 00722 |
|---|
| Company Full Name | 聯合醫務集團有限公司 |
|---|
| Industry | 醫療保健 |
|---|
| Principal Activities | 提供醫療保健服務。 |
|---|
| Listing Date | 2015-11-27 |
|---|
| Listing Rules Era | Old Rules |
|---|
| Listing Rules Chapter | No data |
|---|
| Weighted Voting Rights (WVR) | No |
|---|
| Registered Address (Mainland China) | 香港德輔道中71號永安集團大廈27樓 |
|---|
| Business Address (Hong Kong) | No data |
|---|
| Place of Incorporation | No data |
|---|
| Listing Method | No data |
|---|
| Listing Board | Main Board |
|---|
| Website | http://www.ump.com.hk |
|---|
| Share Registrar | 卓佳證券登記有限公司 |
|---|
| Registrar Contact | (852)2980 1333 |
|---|
| A-Share/US Dual Listing | No data |
|---|
// Offering Information //
| Prospectus Date | 2015-11-17 |
|---|
| Offer Price | HK$ 2.06 / shares |
|---|
| Total Funds Raised | HK$ 113,712,000 |
|---|
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
|---|
// First Day Performance
| First Day Close | Loading... |
|---|
| First Day Open | HK$ 1.81 |
|---|
| First Day Change | -6.31% |
|---|
| First Day Volume | 67576000.0 |
|---|
| First Day Turnover | 127797000.0 |
|---|
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約200.2百萬港元（約60.0%）將用于集團在中國的擴展；
2、約100.1百萬港元（約30.0%）將用于擴大本集團在香港的業務；
3、剩余所得款項約33.4百萬港元（約10.0%）將用作本集團的營運資金及其他一般企業用途。 |
|---|
// Underwriting Syndicate //
整体协调人 (1)
J.P. Morgan Securities (Asia Pacific) Limited
联席账簿管理人 (2)
J.P. Morgan Securities (Asia Pacific) Limited
联昌证券有限公司
联席牵头经办人 (2)
J.P. Morgan Securities (Asia Pacific) Limited
联昌证券有限公司
// Cornerstone Investors //
This stock has no cornerstone investors.
// Directors & Management //
| Chairman | 孫耀江 |
|---|
| Company Secretary | 唐慕婷 |
|---|
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 孫耀江及關連人士(35.72%);周大福(控股)有限公司(15.04%);華潤醫療控股有限公司(11.84%) |
|---|
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.
